Skip to main content
. 2020 Mar 13;9(10):3337–3343. doi: 10.1002/cam4.2986

FIGURE 1.

FIGURE 1

Monotherapy‐induced growth inhibition in the patient‐derived xenograft. In response to monotherapy with oxaliplatin, irinotecan, and 5‐fluorouracil, the tumor growth inhibition rate is 0.23, 0.31, and 0.52, respectively. Eight tumors from four mice were assessed for each treatment. 5‐FU treatment shows statistically significant growth inhibition compared to the control group (P = .0024). P* indicated P < .05